【港股通】国药控股(01099)涨4.65% 机构料下半年药品分销业务或将维持稳健增长

金吾财讯
13 Sep 2024

金吾财讯 | 国药控股(01099)早盘股价随市走高,截至发稿,报17.12港元,涨4.65%,成交额7919.38万港元。中信建投发研报指,国药控股业绩低于该行预期,主要由于器械分销业务承压。该行指,下半年,院内合规销售影响趋于平稳,公司药品分销业务或将维持稳健增长,器械更新换代有望释放增量,器械分销业务有望环比向好,叠加公司持续聚焦构建批零一体化优势,该行看好公司长期业绩潜力稳步释放。该行予维持“买入”评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10